Tandem Diabetes Care
Tandem Diabetes Care Inc is an American medical device company manufacturing insulin delivery systems and technology for diabetes management. The company manufactures t:slim X2 insulin pumps equipped with Control-IQ technology and automated insulin delivery software, alongside disposable cartridges and infusion sets. Main revenue drivers consist of commercial sales of insulin pumps, disposable cartridges, infusion sets, and software subscription upgrades. Tandem Diabetes Care serves Type 1 and insulin-requiring Type 2 diabetes patients, endocrinologists, primary care clinics, and specialty pharmacies across North America, Europe, and Asia-Pacific. The company holds a market-leading global position in automated insulin delivery technology and touchscreen insulin pumps. Headquartered in San Diego, California, Tandem Diabetes Care Inc is listed on the Nasdaq Stock Market.
3 of the funds FundTelligence covers report a position in Tandem Diabetes Care.
- Legal name
- TANDEM DIABETES CARE
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 3
- Exposure themes
- Diabetes Technology, Insulin Delivery, Obesity & Metabolic Health
Funds holding Tandem Diabetes Care
- Mercer Global Small Cap Equity Fund — Mercer · 0.16 % (full portfolio disclosed, December 2025)
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.11 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)